Tag - biogen

 
Menu
Search
 
April 25, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

BIOGEN

Tests for patients suffering from Alzheimer's disease. According to the Alzheimer's Association, the disease is estimated to affect more than 6 million Americans.
WORLD / Science & Health / FOCUS
Apr 24, 2024
Alzheimer's drug adoption in U.S. slowed by doctors' skepticism
There is an entrenched belief among some doctors that treating the memory-robbing disease is futile.
The new Alzheimer's drug lecanemab, branded Leqembi
JAPAN
Dec 13, 2023
New Alzheimer's drug to be covered by health insurance in Japan
The drug, to be launched Dec. 20, will cost around ¥2.98 million per year in Japan but patients will only have to pay a limited share.
Japan Times
WORLD / Science & Health
Jun 19, 2023
New Eisai and Biogen Alzheimer drug faces hurdles in Europe
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price.
Japan Times
JAPAN
Jan 30, 2023
Priority review status given to Alzheimer's drug developed by Eisai and Biogen
The companies said priority review in Japan is granted to new medicines recognized as having high medical utility for serious diseases.
Japan Times
BUSINESS
Jan 16, 2023
Eisai and Biogen apply for approval of Alzheimer's drug in Japan
The two companies hope to gain approval by the end of the year following the U.S. Food and Drug Administration's decision earlier in the month to grant it fast-track approval.
Japan Times
JAPAN / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer’s
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
Japan Times
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug's trial success raises hope for Alzheimer's prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Alzheimer’s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer's by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
BUSINESS / Companies
Jul 6, 2022
Eisai says Alzheimer’s drug will get priority review in U.S.
Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.
Japan Times
BUSINESS
Apr 9, 2022
Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer’s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD
Sep 3, 2021
Lawmakers probe ‘anomalies’ in approval of Biogen Alzheimer’s drug
The congressional inquiry adds to pressure on the U.S. agency charged with regulating products that account for one-fifth of consumer spending.
Japan Times
WORLD / Science & Health
Jul 29, 2021
Doctors blast Biogen Alzheimer approval as ‘regulatory failure’
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency's decision.
Japan Times
COMMENTARY / World
Jul 19, 2021
Latest U.S. Alzheimer's drug fix is a patch job
Most of the FDA's decisions don't receive national attention, which means they may not be rectified until substantial harm is done.
Japan Times
COMMENTARY / World
Jun 14, 2021
Alzheimer’s drug furor highlights U.S. health system’s failures
The FDA didn't deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug 'accelerated approval.”
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
BUSINESS
Jun 9, 2021
Eisai sees potential of new Alzheimer's drug but costs remain concern
The approval by the U.S. Food and Drug Administration of the drug Aduhelm raised hopes, but patients can expect to be charged $56,000 a year.
'Sugar Baby Riri' gets nine-year prison term over romance scam
Mai Watanabe, who went by the moniker “Sugar Baby Riri,” dated older men and swindled them out of money by telling them fictitious heartbreaking stories about herself to gain their sympathy.
Over 40% of Japan's municipalities at risk of vanishing, study finds
Of 1,729 local municipalities nationwide, 744 have been identified as being at risk of disappearing.
'So hot you can't breathe': Extreme heat hits the Philippines
A pedestrian cools himself with a folding hand fan as he waits for a ride along a road in Manila on Wednesday, as extreme heat hit the Philippines.
Tokyo issues strong warning on yen intervention as currency dips further
Finance Minister Shunichi Suzuki speaks during a meeting with U.S. Treasury Secretary Janet Yellen and South Korean Finance Minister Choi Sang-mok on the sidelines of IMF and G20 meetings in Washington last week.
Princess Aiko makes debut at imperial garden party
Princess Aiko attends an imperial garden party in Tokyo on Tuesday.
For amateur sumo, a fresh start offers hope against time-wasting and gamesmanship
Wrestlers prepare for the start of a bout at the 2023 Sumo World Championships in Tokyo. Starting this month, placing one hand on the clay first is no longer allowed.
LDP veteran Nikai's youngest son expected to succeed him in Wakayama
Toshihiro Nikai, former secretary-general of the Liberal Democratic Party, announced in March that he would not run in the next Lower House election to take responsibility for the political funds scandal that rocked his party and his own faction.
New workers name Shohei Ohtani as 'dream boss' for two years running
Shohei Ohtani has been overwhelmingly voted as the “dream boss” for people who started working in April, according to a survey.
A craft beer crawl through Tokyo’s top bars, brewpubs and dives
If all you drink is Asahi, Sapporo and Kirin, you're depriving yourself of some of the best craft beer Tokyo has to offer — and there sure is a lot of it out there.
'Sugar Baby Riri' gets nine-year prison term over romance scam
Mai Watanabe, who went by the moniker “Sugar Baby Riri,” dated older men and swindled them out of money by telling them fictitious heartbreaking stories about herself to gain their sympathy.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Later this month, author Shogo Imamura will open Honmaru, a bookstore that allows other businesses to rent its shelves. It's part of a wave of ideas Japanese booksellers are trying to compete with online spaces.
The story isn't over for Japan's bookstores
By Alex K.T. Martin

SUSTAINABLE JAPAN

Prize winner Maki Imoto catches light with glass
Prize winner Maki Imoto catches light with glass

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER